🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
This study is being done to assess the safety and tolerance of different do...
Status
Completed
Location
Service Des Maladies Du Sang
Start Date
2004-03
Trial ID
NCT00596804
Treatments Being Tested
This is an open-label, Phase II interventional study in order to assess eff...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-11-23
Trial ID
NCT04508647
Treatments Being Tested
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-09
Trial ID
NCT00005787
This phase I study will evaluate the safety and tolerability of an autologo...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01022255
Treatments Being Tested
To determine what side effects and what clinical effect, if any, the admini...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00048555
Treatments Being Tested
This phase Ib/II trial studies the side effects and best dose of toll-like ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2016-11-07
Trial ID
NCT02927964
Treatments Being Tested
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433